Cargando…
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
Differentiated thyroid cancer (DTC), arising from thyroid follicular epithelial cells, is the most common type of thyroid cancer. Despite the well-known utilization of radioiodine treatment in DTC, i.e., iodine-131, radioiodine imaging in DTC is typically performed with iodine-123 and iodine-131, wi...
Autores principales: | Sakulpisuti, Chaninart, Charoenphun, Putthiporn, Chamroonrat, Wichana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370596/ https://www.ncbi.nlm.nih.gov/pubmed/35956886 http://dx.doi.org/10.3390/molecules27154936 |
Ejemplares similares
-
Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022) -
Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center
por: Kanokwongnuwat, Wasit, et al.
Publicado: (2022) -
Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019) -
Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors
por: Jung, Ji-hoon, et al.
Publicado: (2018) -
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013)